Portfolio (Quarterly)
Guide ↗
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
· CIK 0002032331| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | CYTK | CYTOKINETICS INC | Healthcare | 8,836.0 | $753K | 0.16% | +1K | +19.6% | $85.19 | -18.6% |
| 62 | TLT | ISHARES TR | — | 8,700.0 | $752K | 0.16% | +2K | +22.5% | $86.42 | -6.6% |
| 63 | KRE | SPDR SERIES TRUST | — | 10,000.0 | $748K | 0.16% | NEW | — | $74.85 | -1.1% |
| 64 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 28,725.0 | $727K | 0.16% | NEW | — | $25.30 | +5.8% |
| 65 | WDC | WESTERN DIGITAL CORP | Technology | 1,132.0 | $723K | 0.16% | NEW | — | $638.72 | -35.5% |
| 66 | XHB | SPDR SERIES TRUST | — | 6,000.0 | $693K | 0.15% | NEW | — | $115.56 | -15.4% |
| 67 | BNTX | BIONTECH SE | Healthcare | 7,301.0 | $679K | 0.15% | +411.0 | +6.0% | $93.05 | +3.9% |
| 68 | LEGN | LEGEND BIOTECH CORP | Healthcare | 21,669.0 | $626K | 0.14% | NEW | — | $28.88 | -38.8% |
| 69 | KIE | SPDR SERIES TRUST | — | 10,000.0 | $610K | 0.13% | NEW | — | $60.99 | +3.5% |
| 70 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 6,315.0 | $601K | 0.13% | +1K | +22.7% | $95.17 | -3.1% |
| 71 | FLTW | FRANKLIN TEMPLETON ETF TR | — | 5,600.0 | $591K | 0.13% | +2K | +51.4% | $105.53 | -2.9% |
| 72 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 1,035.0 | $561K | 0.12% | +508.0 | +96.4% | $541.83 | -7.7% |
| 73 | XLF | SELECT SECTOR SPDR TR | — | 9,600.0 | $515K | 0.11% | +3K | +54.8% | $53.61 | +6.0% |
| 74 | XLK | SELECT SECTOR SPDR TR | — | 2,600.0 | $495K | 0.11% | +2K | +1200.0% | $190.52 | -3.6% |
| 75 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 5,427.0 | $442K | 0.10% | NEW | — | $81.51 | -13.3% |
| 76 | MRVL | MARVELL TECHNOLOGY INC | Technology | 1,474.0 | $439K | 0.10% | NEW | — | $297.89 | -25.6% |
| 77 | ALMS | ALUMIS INC | Healthcare | 15,396.0 | $433K | 0.09% | +3K | +28.0% | $28.14 | -70.1% |
| 78 | ILMN | ILLUMINA INC | Healthcare | 2,368.0 | $416K | 0.09% | -658.0 | -21.7% | $175.83 | +26.4% |
| 79 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,298.0 | $404K | 0.09% | -6K | -64.7% | $122.58 | +17.0% |
| 80 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 39,233.0 | $386K | 0.08% | NEW | — | $9.85 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
25.2%
Financial Services
20.0%
Industrials
18.0%
Technology
17.1%
Utilities
7.9%
Energy
7.6%
Communication Services
3.9%
Consumer Defensive
0.2%
Real Estate
0.1%
Consumer Cyclical
0.1%